A force for change: the Global Fund at 30 months

A force for change: the Global Fund at 30 months

The Global Fund to Fight AIDS, Tuberculosis and Malaria: what difference does it make?

This review from the Global Fund to Fight AIDS, Tuberculosis and Malaria is a self-evaluation after 30 months of activity. Country profiles of the Fund’s activities in Ghana, Honduras, Indonesia, Rwanda and Zambia are also provided. Key projected coverage figures include the following: 1.6 million people will be placed on antiretroviral (ARV) treatment for HIV over the next five years, representing a six-fold increase; approximately 3.5 million additional TB cases will be treated with DOTS (directly observed treatment strategy) and four times as many patients treated for multi-drug resistant TB; 145 million treatments of artemisinin combination therapy (ACT) for malaria will be financed, with the potential for millions more following a large-scale shift to ACT, and 108 million insecticide-treated bednets will be provided.

The review acknowledges that these projected figures do not by themselves enable the world to reach global disease control targets. However, it emphasises that Global Fund commitments to date represent a significant increase over projections for AIDS, TB and malaria funding that existed before the Fund was founded. It concludes that its biggest impact will be in reducing the number of global deaths from malaria, previously the most underfunded of the three epidemics. [adapted from author]

  1. How good is this research?

    Assessing the quality of research can be a tricky business. This blog from our editor offers some tools and tips.